5 Oral: Preliminary Results from a Phase Ia/Ib, Open-label, Multicenter Study of ZL-1310, a DLL3-targeted ADC, to Evaluate the Safety, Tolerability, and Pharmacokinetics in Subjects with Small Cell Lung Cancer - NCT06179069
Titel:
5 Oral: Preliminary Results from a Phase Ia/Ib, Open-label, Multicenter Study of ZL-1310, a DLL3-targeted ADC, to Evaluate the Safety, Tolerability, and Pharmacokinetics in Subjects with Small Cell Lung Cancer - NCT06179069
Auteur:
Spira, A. Dowlati, A. Zhao, J. Patel, M.R. Wang, Q. Dong, X. Gutierrez, M. Wang, Z. Dy, G. Liu, X. Fu, Y. Shen, X. Zhou, R. Wu, Y.L.